OncoPlexDx is a CLIA-certified cancer diagnostics laboratory in Rockville, MD that provides clinical proteomics for patient care. By quantitating proteins, It provide information that helps physicians choose targeted therapies and avoid therapies that won’t work.

NantOmics develops cloud-based molecular profiling tools that help guide cancer patients. It is a molecular diagnostics company, develops molecular profiling solutions that identify personalized treatment options for cancer patients and their providers at the point of care. It offers GPS Cancer test that provides a molecular profile of patient’s cancer to inform personalized treatment strategies to oncologists and OncoPlexDx Targeted Proteomic panel that provides quantitative protein biomarker information for multiple clinically relevant proteins yielding insights into the biology driving the growth of the patient’s cancer. Patrick Soon-Shiong founded NantOmics in 2012, with its headquarters in Culver City, California. NantOmics operates as a subsidiary of NantWorks.

The mission of Integrated Diagnostics is to leverage powerful emerging technologies in the development of diagnostic products that enable physicians and patients to manage complex and important diseases such as cancer, diabetes and Alzheimer's through blood tests that can monitor tens to hundreds of disease markers simultaneously. The company plans to develop a pipeline of game-changing diagnostic products that enable the diagnosis and prognosis of a variety of diseases. The company is based on the concept of a systems view of disease where pathophysiology arises from disease-perturbed networks of proteins, genes and other molecules.

Biodesix is a data-driven diagnostic solutions company that provides lung cancer diagnostic testing and biopharma services. The company provides physicians with diagnostic tests for earlier disease detection, more accurate diagnosis, disease monitoring, and better therapeutic guidance, which may lead to improved patient outcomes. Biodesix discovers, develops, and commercializes multivariate protein diagnostics based on its proprietary mass spectrometry-based discovery platform. VeriStrat, a multivariate serum protein test, is Biodesix’s first product developed with this technology. The commercially available test provides oncologists with information to help them select between erlotinib and single-agent chemotherapy for advanced lung cancer patients. Tests are processed in Biodesix’s CLIA-certified laboratory and results are reported in less than 72 hours. In addition to developing novel diagnostics independently, the company also partners with biotechnology and pharmaceutical companies to develop companion diagnostics to improve the utility of therapeutic agents.

DH Technologies Development Pte Ltd. engages in holding or owning of companies. The company was founded on August 3, 2009 and is headquartered in Singapore.

Micromass UK Ltd. develops, manufactures and distributes analytical instruments. The firm manufactures a line of mass spectrometry products. It offers various platforms for drug discovery applications based on its technology. Mircomass is a wholly owned subsidiary of Waters Corp. The company was founded in 1996 and is headquartered in Manchester, UK.

Thermo Finnigan Corp., a subsidiary of Thermo Fisher Scientific, Inc., is a company headquartered in San Jose, CA. The firm provides investment services.

PolyQuant is an innovative platform technology for the absolute multiplex quantitation of proteins, PolyQuant offers cost-effective products and services for proteomics and pharma. The technology allows large-scale acquisition of protein levels, which can be leveraged in drug discovery and biomarker validation. The QconCAT technology is particularly well suited for the rapid development of protein assays, which typically takes 12 weeks and less. QconCAT-based reference standards for a wide range of topics, such as disease states or metabolic pathways, are in the pipeline or can be custom designed on request.

IT-IS International Ltd. engages in the development and manufacturing of PCR devices for the life sciences and food testing industry. It offers multichannel spectrometer, high power thermal system, data analysis and PCR analysis algorithms, graphical user interfaces, mass spectrometry analysis, DTI grant, business accelerator network, and thermaxis. The company was founded by Benjamin Webster, Roderic Fuerst, and James Howell in 2004 and is headquartered in the United Kingdom.

Nuclea Biotechnologies, LLC is headquartered in Pittsfield, Massachusetts with additional operations in Worcester, Massachusetts. Nuclea has three lines of business, each of which is operated by a separate wholly-owned subsidiary: Nuclea Diagnostic Laboratories (“NDL”) which has developed and is commercializing eleven unique diagnostic tests for colon, breast, leukemia, lung and prostate cancer; Nuclea Biomarkers (“NBM”) which performs research leading to novel molecular oncology therapeutics and diagnostics for the pharmaceutical and biotechnology industries and performs services by analyzing and testing the efficacy and validating other indications of existing therapeutics utilizing a highly characterized and consented patient database; and Nuclea Biotherapeutics (“NBT”) which has developed several therapeutics now in animal trials.

CEA is a French government-funded technological research organisation. A prominent player in the European Research Area, it is involved in setting up collaborative projects with many partners around the world. The CEA is the French Alternative Energies and Atomic Energy Commission (Commissariat à l'énergie atomique et aux énergies alternatives). It is a public body established in October 1945 by General de Gaulle. A leader in research, development and innovation, the CEA mission statement has two main objectives: To become the leading technological research organization in Europe and to ensure that the nuclear deterrent remains effective in the future. The CEA is active in four main areas: low-carbon energies, defense and security, information technologies and health technologies. In each of these fields, the CEA maintains a cross-disciplinary culture of engineers and researchers, building on the synergies between fundamental and technological research. The total CEA workforce consisted of 15 838 employees. Across the whole of the CEA (including both civilian and military research), there were 1556 PhD students and 293 post-docs. The CEA is based in ten research centers in France, each specializing in specific fields. The laboratories are located in the Paris region, the Rhône-Alpes, the Rhône valley, the Provence-Alpes-Côte d'Azur region, Aquitaine, Central France and Burgundy. The CEA benefits from the strong regional identities of these laboratories and the partnerships forged with other research centers, local authorities and universities.

Jiangsu Keli Color Quality Medical Equipment Co., Ltd., established on 2016-06-01, Business scope includes medical research,Test Development Services;Technology development in the medical field,technical consulting,technology transfer;Chemical raw materials and products(Free of Hazardous Chemicals)Sales;Test and analysis instrument(Does not include measuring instruments)manufacture,Sales;one,two,Production of Class III Medical Devices,Sales;Medical equipment rental;Marketing Planning Service,Market Research Services,Trade Advisory Services,Self-operated and agent import and export business of various commodities and technologies(Except for commodities and technologies that are restricted by the state to be operated by enterprises or prohibited from import and export).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Jiangsu Jintai Life Technology Co., Ltd., established on 2011-08-30, Business scope includes technology research and development of new biological products,technology transfer,technical consulting;Health Testing and Consultation.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Shanghai Kelimeta Biomedical Technology Co., Ltd., established on 2012-08-03, Business scope includes biotechnology,Medical Technology,medical instruments,Technical development in the professional field of testing services,technology transfer,technical consulting,Technical Services,marketing planning,Conference and exhibition services,III,IIkind:Clinical Laboratory Analytical Instruments(In vitro diagnostic reagents containing medical devices),Class I medical device,Chemical Products(Removal of hazardous chemicals,Monitor Chemicals,firecrackers,civilian explosives,precursor chemicals)promotion of,Own Equipment Rental. [Items subject to approval by law,Business activities can only be carried out after approval by relevant departments]

Shanghai Aike Thermo Medical Equipment Co., Ltd., established on 2016-06-29, Business scope includes medical devices,Biological Technology,Technology development in the field of medical science and technology,technology transfer,technical consulting,Technical Services;marketing planning,Conference and exhibition services,I,II,IIIclass of medical devices,Chemical Products(Removal of hazardous chemicals,Monitor Chemicals,firecrackers,civilian explosives,precursor chemicals),computer,Sales of software and auxiliary equipment,account Serive,Exhibition display service,software development,Computer Information System Integration,data processing,e-commerce(Not to engage in financial business),Own Equipment Rental,food circulation. [Items subject to approval by law,Business activities can only be carried out after approval by relevant departments]

Guangzhou Keli Mass Spectrometry Medical Equipment Co., Ltd., established on 2015-01-29, Business scope includes biopharmaceutical manufacturing;Manufacturing of medical laboratory equipment and appliances;Licensed medical device business;Manufacturing of experimental analysis instruments;Own real estate business activities;Medical equipment rental service;Space lease(Without storage);Sales of packaging materials;Trade Advisory Services;Manufacturing of other non-hazardous basic chemical raw materials;Manufacturing of organic chemical raw materials(Monitor Chemicals,Excluding hazardous chemicals);Sales of Biological Products(Does not include licensed operations);Sales of biological diagnostic reagents and kits(Does not include license approval items);Import and export(Excluding franchised products);Market Research Services;Cold storage rental service;Machinery and Equipment Leasing;Medical supplies and equipment retail(Does not contain drugs and medical devices);Biomedical Technology Research;Realtor;Medical Research and Experimental Development;Instrument wholesale;Science and Technology Information Consulting Services;Marketing Planning Service;Office equipment rental service;Technology Import and Export;Operation of non-licensed medical devices;Chemical Engineering Research Services;Biotechnology Extension Services;trade agent;